Gian Luca Rampioni Vinciguerra

This researcher studies the molecular mechanisms underlying cancer development and drug resistance, with a particular focus on breast, pancreatic, and ovarian cancers. Their work examines how small RNA molecules (like microRNAs), DNA repair proteins, and cellular metabolism changes contribute to tumor growth and resistance to treatments such as CDK4/6 inhibitors and chemotherapy. Much of the research uses mouse models and patient tissue samples to understand how cancer cells adapt and evade therapy.

Publication output has been variable over the past decade with a sharp spike in 2023, following periods of lower activity, suggesting bursty rather than steadily increasing productivity.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026